Aims and Scope of Drug Target Insights
Drug Target Insights (DTI) is an international, indexed, peer-reviewed, open access, online only journal, published once a year. It covers current developments in all areas of the field of clinical therapeutics and focusing on molecular drug targets which include disease-specific proteins, receptors, enzymes, and genes. The journal seeks to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life. The journal welcomes unsolicited article proposals. All articles are listed on PubMed and are freely available via PubMed Central. Less
Key Metrics
CiteScore 

4.3
SJR 

Q2Clinical Biochemistry

SNIP 

0.65
Recommended pre-submission checks
Powered by 

Drug Target Insights Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | ABOUTSCIENCE SRL |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 1500 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Drug Target Insights ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drug Target Insights
Molecular docking and dynamics analysis of selected phytocompounds against multi-targeted hepatocellular carcinoma.
- 23 Apr 2026
- Drug target insights
Alternative model organisms: growing popularity, and the challenges.
- 17 Feb 2026
- Drug target insights
Antioxidant potential of a new macrocyclic bisbibenzyl and other compounds from Combretum molle: in vitro and docking analyses
- 18 Dec 2025
- Drug Target Insights
Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series
- 9 Dec 2025
- Drug Target Insights
Co-occurrence of genes encoding carbapenem resistance and aminoglycoside resistance in clinical isolates of Enterobacterales
- 27 Oct 2025
- Drug Target Insights
Integrated in vitro, microarray, and network pharmacology analysis reveals the multi-target anti-diabetic potential of Vigna unguiculata
- 21 Aug 2025
- Drug Target Insights
Molecular docking and dynamics analysis of selected phytocompounds against multi-targeted hepatocellular carcinoma.
- 23 Apr 2026
- Drug target insights
Alternative model organisms: growing popularity, and the challenges.
- 17 Feb 2026
- Drug target insights
Antioxidant potential of a new macrocyclic bisbibenzyl and other compounds from Combretum molle: in vitro and docking analyses
- 18 Dec 2025
- Drug Target Insights
Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series
- 9 Dec 2025
- Drug Target Insights
Co-occurrence of genes encoding carbapenem resistance and aminoglycoside resistance in clinical isolates of Enterobacterales
- 27 Oct 2025
- Drug Target Insights
Integrated in vitro, microarray, and network pharmacology analysis reveals the multi-target anti-diabetic potential of Vigna unguiculata
- 21 Aug 2025
- Drug Target Insights